NM
Neuros Medical, Inc.
SEC filingBiotechnology · Aliso Viejo, CA
Amount raised$56Msold at filing
Total offering$65M$9M still open
Investors in the raise28count reported to the SEC
FiledAug 6, 2025first sale Jul 9, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David VeinoExecutive Officer, Director
Joyce EronyDirector
William HarringtonDirector
Fouad AzzamDirector
Zach StassenExecutive Officer
Casey TanseyDirector
Marc-Andre MarcotteDirector
Randy BanDirector
Executive officers, directors and promoters as listed on the Form D.